Effect of lattice CO2 laser combined with Kegel exercise mild moderate stress urinary incontinence and postpartum depression anxiety

Table 1 Comparison of baseline data, n (%)

Baseline data	Group S (n = 41)	Group L (n = 41)	t/χ2 value	P value
Age (years)	28.19 ± 3.25	28.34 ± 3.39	0.205	0.838
Body mass index (kg/m2)	23.45 ± 2.61	23.86 ± 2.83	0.682	0.497
Degree of education			0.201	0.645
High school or below	16 (60.98)	18 (43.90)
College degree or above	25 (39.02)	23 (56.10)
Reproductive history			0.195	0.659
Primipara	22 (53.66)	20 (48.78)
Multipara	19 (46.34)	21 (51.22)
Severity of postpartum SUI			0.210	0.647
Slight	27 (65.85)	25 (60.98)
Moderate	14 (34.15)	16 (39.02)

SUI: Stress urinary incontinence.

Table 2 Comparison of urinary incontinence symptom score and urinary incontinence quality of life score

Group	n	ICI-Q-SF scores			I-QOL scores
		Before treatment	At the end of treatment	3 months after treatment	Before treatment	At the end of treatment	3 months after treatment
Group S	41	11.94 ± 2.76	8.19 ± 2.63	9.53 ± 2.85	68.32 ± 13.91	76.64 ± 10.32	71.98 ± 10.05
Group L	41	12.35 ± 3.28	5.82 ± 1.74	5.92 ± 1.79	67.56 ± 12.85	88.58 ± 11.16	86.59 ± 10.16
t value		0.612	4.812	6.868	0.257	5.034	6.546
P value		0.541	< 0.001	< 0.001	0.798	< 0.001	< 0.001

ICI-Q-SF: International commission on urinary incontinence questionnaire short form; I-QQL: Incontinence quality of life questionnaire.

Table 3 Comparison of clinical efficacy, n (%)

Group	n	At the end of treatment			Total efficiency	3 months after treatment			Total efficiency
		Significant effect	Effective	Invalid		Significant effect	Effective	Invalid
Group S	41	15 (36.58)	13 (31.71)	13 (31.71)	28 (68.29)	13 (31.71)	12 (29.27)	16 (39.02)	25 (60.98)
Group L	41	21 (51.22)	15 (36.59)	5 (12.19)	36 (87.81)	21 (51.22)	13 (31.71)	7 (17.07)	34 (82.93)
χ2 value		1.783	0.217	4.556	4.556	3.216	0.058	4.895	4.895
P value		0.182	0.641	0.033	0.033	0.076	0.81	0.027	0.027

Table 4 Comparison of postpartum depression and anxiety scores

Group	n	EPDS scores			PSAS scores
		Before treatment	At the end of treatment	3 months after treatment	Before treatment	At the end of treatment	3 months after treatment
Group S	41	9.89 ± 2.64	8.46 ± 1.35	8.65 ± 1.46	141.92 ± 27.85	92.57 ± 17.83	96.95 ± 18.16
Group L	41	9.94 ± 2.72	7.49 ± 1.08	7.51 ± 1.17	143.18 ± 26.96	71.63 ± 15.92	73.82 ± 16.73
t value		0.084	3.593	3.902	0.208	5.609	5.998
P value		0.933	0.001	< 0.001	0.836	< 0.001	< 0.001

EPDS: Edinburgh postnatal depression scale; PSAS: Postnatal specific anxiety scale.

Table 5 Comparison of adverse reaction situations, n (%)

Group	n	Vaginal bleeding	Coital pain	Vulvar itching	Increased secretion	Urge incontinence
Group S	41	1 (2.44)	2 (4.88)	2 (4.88)	2 (4.88)	1 (2.44)
Group L	41	0 (0.00)	1 (2.44)	3 (7.32)	0 (0.00)	2 (4.88)
χ2 value		1.012	0.346	0.213	2.635	0.346
P value		0.314	0.556	0.644	0.105	0.556